Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice

PATH Consortium Members, Elisabeth M P Steeghs, Geraldine R Vink, Marloes A G Elferink, Quirinus J M Voorham, Hans Gelderblom, Iris D Nagtegaal, Katrien Grünberg, Marjolijn J L Ligtenberg*, Ed Schuuring

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    41 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Keyphrases